Flavonoid consumption may decrease risk of ovarian cancer
the ONA take:
According to a new study published in the American Journal of Clinical Nutrition, researchers from the University of East Anglia in Norwich, England, have found that consuming foods containing flavonols and flavanones are associated with a reduced risk for developing epithelial ovarian cancer.
Previous studies have suggested that a fruit and vegetable-rich diet may be associated with a decreased risk of ovarian cancer, but other studies have demonstrated inconsistent results. The researchers of this study hypothesized that flavonoids might be the compound in plants that may reduce the risk of ovarian cancer because flavonoids alter signaling pathways and control cancer-inflammation pathways. Flavonoids are found in apples, citrus fruit, juices, grapes, red wine, and tea.
For the study, researchers analyzed the dietary habits of 171,940 women from the Nurses' Health Study and Nurses' Health Study II over 30 years. The main sources of flavonoids were found to be juices, citrus fruits, black tea, onions, and apples. During the follow-up period, 723 cases of ovarian cancer occurred. Analyses showed that two cups of black tea daily was associated with a 31% decreased risk for developing ovarian cancer. The researchers recommend future prospective trials to confirm the results of this study.
Consuming foods containing flavonols associated with reduced risk of developing epithelial ovarian cancer.
The researchers, from the University of East Anglia (UEA) in the UK, publish their results in the American Journal of Clinical Nutrition. According to the team, ovarian cancer affects over 6,500 women in the UK and 20,000 women in the US each year. Epithelial ovarian cancer - the most common form of the disease - is where the cancer begins in the surface layer covering the ovary.
This type of cancer "remains a highly lethal malignancy," note the researchers, adding that few modifiable risk factors have been established.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|